We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ABCL market cap is 1.17B. The company's latest EPS is USD -0.5059 and P/E is -7.93.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 101.38M | 21.55M | 12.19M | 10.06M | 6.6M |
Operating Income | 52.77M | -36.22M | -64.87M | -51.39M | -54.89M |
Net Income | 26.62M | -29.89M | -40.11M | -30.53M | -28.61M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 233.16M | 375.2M | 485.42M | 38.03M |
Operating Income | 183.17M | 249.93M | 282.95M | -237.21M |
Net Income | 118.92M | 153.46M | 158.52M | -146.4M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 1.55B | 1.54B | 1.5B | 1.54B | 1.51B |
Total Liabilities | 302.24M | 307.63M | 289.42M | 342.34M | 329.42M |
Total Equity | 1.25B | 1.23B | 1.21B | 1.19B | 1.18B |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 1.01B | 1.32B | 1.54B | 1.49B |
Total Liabilities | 175.03M | 292.84M | 307.63M | 335.78M |
Total Equity | 830.51M | 1.03B | 1.23B | 1.15B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | 246.45M | 277.36M | -44.06M | -24.16M | -24.27M |
Investing | -335.56M | -352.63M | -149.61M | -184M | -196.79M |
Financing | -1.98M | -1.63M | -458k | -39k | 6.59M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 22.69M | 244.58M | 277.36M | -43.88M |
Investing | -119.78M | -332.25M | -352.63M | -221.11M |
Financing | 683.65M | -3.89M | -1.63M | 10.36M |
Market Cap | 1.17B |
Price to Earnings Ratio | -7.93 |
Price to Sales Ratio | 30.52 |
Price to Cash Ratio | 8.7 |
Price to Book Ratio | 1.01 |
Dividend Yield | - |
Shares Outstanding | 289.36M |
Average Volume (1 week) | 1.08M |
Average Volume (1 Month) | 1.05M |
52 Week Change | -43.91% |
52 Week High | 8.05 |
52 Week Low | 3.79 |
Spread (Intraday) | 0.08 (2%) |
Company Name | AbCellera Biologics Inc |
Address |
2215 yukon street vancouver, british columbia V5Y 0A1 |
Website | https://www.abcellera.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions